Clinical Trial Update: Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 [Phase 4]

View source ↗

Summary

Phase 4 randomized trial comparing high-dose valacyclovir with once-daily valacyclovir in people with HSV-2 genital herpes has completed. The results were poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genital Herpes

Drugs mentioned

• Valacyclovir (Valtrex) (Valacyclovir)

Snippet

Sponsor: University of Washington | Conditions: Genital Herpes | Phase 4 | Status: COMPLETED | Results posted: 2017-03-09